4th Quarter - Report

THE MCMANUS GROUP for AMGEN

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Regulatory and legislative activities regarding 340B program.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Access and reimbursement for Part B drugs. Opposition to proposed Part B demo (81 FR 13229). Education regarding CMMI. Support for H.R.5122 - To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5122 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.